VentriPoint Diagnostics Ltd. (VPTDF)

USD 0.07

(-2.72%)

Market Cap (In USD)

11.56 Million

Revenue (In USD)

49.18 Thousand

Net Income (In USD)

-4.87 Million

Avg. Volume

23.98 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.057-0.2687
PE
-
EPS
-
Beta Value
0.388
ISIN
CA92281P2008
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Devices
CEO
Mr. Hugh MacNaught
Employee Count
-
Website
https://www.ventripoint.com
Ipo Date
2010-09-22
Details
Ventripoint Diagnostics Ltd., a medical device company, develops and commercializes diagnostic tools that monitor patients with heart disease worldwide. The company offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient's heart chambers; VMS+ software for use in creating three-dimensional model of the heart chamber using echocardiograms and magnetic resonance imaging images; and obtain reproducible, accurate volumetric measurement, and ejection fraction. It also develops a suite of applications for various heart diseases and imaging modalities, including congenital heart disease, pulmonary hypertension, cardiotoxicity in oncology patients, and Covid-19 related heart issues. The company was incorporated in 2004 and is based in Toronto, Canada.